(Q21562343)

2

Catarina D

Campbell

1 reference

6 September 2022

Sarah M Kehoe

3

Sarah M

Kehoe

1 reference

6 September 2022

Adam J Bass

4

Adam J

Bass

1 reference

6 September 2022

Charles Hatton

5

Charles

Hatton

1 reference

6 September 2022

Lili Niu

6

Lili

Niu

1 reference

6 September 2022

Matt Davis

7

Matt

Davis

1 reference

6 September 2022

Keluo Yao

8

Keluo

Yao

1 reference

6 September 2022

Megan Hanna

9

Megan

Hanna

1 reference

6 September 2022

Chandrani Mondal

10

Chandrani

Mondal

1 reference

6 September 2022

Lauren Luongo

11

Lauren

Luongo

1 reference

6 September 2022

Caroline M Emery

12

Caroline M

Emery

1 reference

6 September 2022

Alissa C Baker

13

Alissa C

Baker

1 reference

6 September 2022

Juliet Philips

14

Juliet

Philips

1 reference

6 September 2022

Deborah J Goff

15

Deborah J

Goff

1 reference

6 September 2022

Michelangelo Fiorentino

16

Michelangelo

Fiorentino

1 reference

6 September 2022

Jennifer Chan

19

Jennifer

Chan

1 reference

6 September 2022

Yuexiang Wang

20

Yuexiang

Wang

1 reference

6 September 2022

Jonathan A Fletcher

21

Jonathan A

Fletcher

1 reference

6 September 2022

Gianni Corso

23

Gianni

Corso

1 reference

6 September 2022

Franco Roviello

24

Franco

Roviello

1 reference

6 September 2022

Ramesh Shivdasani

25

Ramesh

Shivdasani

1 reference

6 September 2022

Keith L Ligon

27

Keith L

Ligon

1 reference

6 September 2022

Charles D Stiles

28

Charles D

Creative Commons Attribution 4.0 International

Stiles

1 reference

6 September 2022

language of work or name

English

0 references

publication date

2009

0 references

published in

PLOS One

0 references

volume

4

0 references

page(s)

e7887

0 references

issue

11

0 references

copyright license

start time

18 November 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Accurate whole human genome sequencing using reversible terminator chemistry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774511

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774511

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774511

The Sequence of the Human Genome

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774511

A transforming mutation in the pleckstrin homology domain of AKT1 in cancer

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774511

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774511

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774511

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774511

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774511

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774511

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774511

Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774511

Combinatorial patterns of somatic gene mutations in cancer

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774511

BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774511

Cellular uptake of the tyrosine kinase inhibitors imatinib and AMN107 in gastrointestinal stromal tumor cell lines

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774511

Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774511

PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer.

30 May 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0007887

Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0007887

Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0007887

PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0007887

Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0007887

Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0007887

High-throughput oncogene mutation profiling in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0007887

Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19924296

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0007887

1 reference

3471160

ADS bibcode

2009PLoSO...4.7887M

0 references

3471160

1 reference

1 reference

1 reference